Mengxia Li

Mengxia Li

Auto-generated profile, based on publicly available information

Mengxia Li

State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, Department of Biochemistry, Innovation Center for Evolutionary Synthetic Biology, School of Life Sciences, Sun Yat-sen University , Guangzhou 510275

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in EMBO Reports
Verified
Journal Article
Closed access
LCLiutao Chen
Liutao Chen
YFYonggui Fu
Yonggui Fu
ZHZhijie Hu
Zhijie Hu
KDKe Deng
Ke Deng
ZSZili Song
Zili Song
AXAnlong Xu
Anlong Xu

6 March 2025 in Protein & Cell
Verified
Journal Article
Open access
MLMengxia Li
Mengxia Li
ZHZhijie Hu
Zhijie Hu
YHYingye Huang
Yingye Huang
YHYuting Han
Yuting Han
CLCheng Liang
Cheng Liang
AXAnlong Xu
Anlong Xu
Protein liquid–liquid phase separation (LLPS), a pivotal phenomenon intricately linked to cellular processes, is regulated by various other proteins. However, there is still a lack of high-throughput methods for screening protein regulators of LLPS in target proteins. Here, we developed a CRISPR/Cas9-based screening method to identify protein phase separation regulators by integrating bimolecular fluorescence complementation (BiFC) and fluorescence-activated cell sorting (FACS). Using this newly developed method, we screened the RNA-binding proteins that regulate PABPN1 phase separation and identified the tumor suppressor QKI as a promoter of PABPN1 phase separation. Furthermore, QKI exhibits decreased expression levels and diminished nuclear localization in colorectal cancer cells, resulting in reduced PABPN1 phase separation, which, in turn, promotes alternative polyadenylation (APA), cell proliferation, and migration in colorectal cancer.